SAM #FDA-CITELINE-1292051

HHS and FDA Sole Source Procurement for Citeline Trialtrove+ Subscription Services

This opportunity is for the U.S. Department of Health and Human Services (HHS), including the Food and Drug Administration (FDA), to procure specialized subscription services for Citeline's Trialtrove+ clinical trial intelligence platform. - Government Buyer: - U.S. Department of Health and Human Services (HHS) - Program Support Center Acquisition Management Service (ASA) - ASFR/OMAS office - U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) - OEMs and Vendors: - Citeline (OEM) - Caerus US 1 Inc. (vendor/distributor) - Products/Services Requested: - Citeline Trialtrove+ subscription service - 30 Trialtrove+ licenses for FDA users - 2 one-hour training sessions (recordable by FDA) - 12 monthly FDA user metrics reports - Unique/Notable Requirements: - Sole source procurement for Citeline Trialtrove+ subscription - Subscription provides global clinical trial data intelligence, supporting expedited IND Pilot Program - Training and monthly usage reporting included - Intended to address limitations of ClinicalTrials.gov for early-stage clinical trial data - Estimated contract value: $87,000 for a one-year subscription period - Period of performance: One-year subscription, with training and reporting deliverables throughout the year

Description

HHS requires access to Citeline data and related subscription services to support requirements in the Notice of Intent to Sole Soruce/Combined Synopsis-Solicitation and Attachment# 1 Statement of Work.

View original listing